Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil T Parkin

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Viral Hepatitis|September 26, 2025
Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource-Limited SettingsHuma Qureshi, Jesse A Canchola, Ghayas Hai, et al.
Journal of Clinical Microbiology|January 25, 2013
Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimensGavin A Cloherty, James Rhoads, Thomas P Young, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 proteaseThomas P Young, Neil T Parkin, Eric Stawiski, et al.
Journal of Clinical Microbiology|February 4, 2011
Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutationsThomas P Young, Gavin Cloherty, Signe Fransen, et al.
AIDS (London, England)|July 19, 2006
Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptaseBen Berkhout, Nicole Kt Back, Anthony de Ronde, et al.
Viruses|December 22, 2020
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation SequencingCheryl Jennings, Neil T Parkin, Daniel J Zaccaro, et al.
The Journal of Biological Chemistry|October 11, 2003
Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutationsJérôme Deval, Kirsten L White, Michael D Miller, et al.
Antiviral Research|April 22, 2014
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settingsNicolas Sluis-Cremer, Michael R Jordan, Kelly Huber, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2012
Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility dataEdward P Acosta, Kay L Limoli, Lan Trinh, et al.
Journal of Viral Hepatitis|January 3, 2024
Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurementHuma Qureshi, Ana Carrasco Duran, Hassan Mahmood, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Viral Hepatitis|September 26, 2025
Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource-Limited SettingsHuma Qureshi, Jesse A Canchola, Ghayas Hai, et al.
Journal of Clinical Microbiology|January 25, 2013
Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimensGavin A Cloherty, James Rhoads, Thomas P Young, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 proteaseThomas P Young, Neil T Parkin, Eric Stawiski, et al.
Journal of Clinical Microbiology|February 4, 2011
Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutationsThomas P Young, Gavin Cloherty, Signe Fransen, et al.
AIDS (London, England)|July 19, 2006
Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptaseBen Berkhout, Nicole Kt Back, Anthony de Ronde, et al.
Viruses|December 22, 2020
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation SequencingCheryl Jennings, Neil T Parkin, Daniel J Zaccaro, et al.
The Journal of Biological Chemistry|October 11, 2003
Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutationsJérôme Deval, Kirsten L White, Michael D Miller, et al.
Antiviral Research|April 22, 2014
E138A in HIV-1 reverse transcriptase is more common in subtype C than B: implications for rilpivirine use in resource-limited settingsNicolas Sluis-Cremer, Michael R Jordan, Kelly Huber, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2012
Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility dataEdward P Acosta, Kay L Limoli, Lan Trinh, et al.
Journal of Viral Hepatitis|January 3, 2024
Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral load measurementHuma Qureshi, Ana Carrasco Duran, Hassan Mahmood, et al.
Pageof 4